Siebert, Reiner
Universitätsklinikum Ulm,
Germany
2025 Rank: 124394
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2238 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124394 | 102592 |
| Total Cites | 6102 | 7014 |
| H-index | 25 | 27 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 5 | 10 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 270 | 341 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 4835 | 5284 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.33 |
| Self-Citation Percentage |
13.00%
|
|
Siebert, Reiner
Universität Ulm,
Germany
2024 Rank: 123989
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2352 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123989 | 113632 |
| Total Cites | 5964 | 6919 |
| H-index | 24 | 26 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 3 | 3 |
| Number of Single+First+Last Authored Papers | 131 | 131 |
| Total Cites to Single+First+Last Authored Papers | 268 | 338 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 4643 | 5099 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.36 |
| Self-Citation Percentage |
13.80%
|
|
Siebert, Reiner
Universitätsklinikum Ulm,
Germany
2023 Rank: 140032
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2864 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 140032 | 140577 |
| Total Cites | 4804 | 5538 |
| H-index | 24 | 26 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 3 | 3 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 234 | 292 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 3837 | 4184 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.32 |
| Self-Citation Percentage |
13.25%
|
|
Siebert, Reiner
Universitätsklinikum Ulm,
Germany
2022 Rank: 124060
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2857 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124060 | 120123 |
| Total Cites | 4820 | 5501 |
| H-index | 24 | 25 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 3 | 4 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 254 | 310 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 3945 | 4291 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.28 |
| Self-Citation Percentage |
12.38%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.